Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VRT vs MRNA✓SelectedUSD · MRNAVRT vs MRNA performance historyLatest closeAs of-6.63%11/16
Stock and ETF performance explorer

VRT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+606.5%
MRNA return
-8.0%
Excess return
+614.5%
Maximum drawdown
-69.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-6.6%-3.6%-3.0%-6.4%
7D-5.9%-20.0%+14.1%-4.5%
30D-8.6%-1.3%-7.3%-8.6%
3M-35.8%+240.0%-275.7%-44.3%
6M-49.1%+339.0%-388.1%-58.9%
YTD+16.5%+630.0%-613.4%-17.1%
1Y+10.5%+769.1%-758.6%-24.6%
3Y+342.1%+181.2%+160.9%+251.7%
5Y+606.5%-8.1%+614.6%+558.0%
All+606.5%-8.0%+614.5%+558.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling